1. Diagnostic options for pulmonary fungal diseases in Africa
- Author
-
Martha F. Mushi, Sherif M. Zaki, Richard O.S. Penney, Sanata Bamba, Marius Paulin Ngouanom Kuate, Eric L. Kasamba, Fructueux M. Amona, Sara Werkneh, Buntung Ceesay, Bakary Dibba, Bright Ocansey, Ousmane Sy, Mohammed Yahaya, Darlinda Jiba, Tom Boyles, Sixbert I. Mkumbaye, Richard Kwizera, Elopy Sibanda, David Koffi, Yolande Sissinto Savi De Tove, Emma Orefuwa, and David W. Denning
- Subjects
Pulmonary and Respiratory Medicine - Abstract
BackgroundFungal lung diseases are global in distribution and require specific tests for diagnosis. We report a survey of diagnostic service provision in Africa.MethodsA written questionnaire was followed by a video conference call with each respondent(s) and external validation. To disseminate the questionnaire, a snowball sample was used.ResultsData were successfully collected from 50 of 51 African countries with populations >1 million. The questionnaire was completed by respondents affiliated with 72 health facilities. Of these 72 respondents, 33 (45.8%) reported data for the whole country while others reported data for a specific region/province within their country. In the public sector, chest X-ray and computed tomography are performed often in 49 countries (98%) and occasionally in 37 countries (74%), and less often in the private sector. Bronchoscopy and spirometry were done often in 28 countries (56%) and occasionally in 18 countries (36%) in the tertiary health facilities of public sector. The most conducted laboratory diagnostic assay was fungal culture (often or occasionally) in 29 countries (58%). In collaboration with the Africa Centre for Disease Control and Prevention, regional webinars and individual country profiles provided further data validation.ConclusionThis survey has found a huge disparity of diagnostic test capability across the African continent. Some good examples of good diagnostic provision and very high-quality care were seen, but this was unusual. The unavailability of essential testing such as spirometry was noted, which has a high impact in the diagnosis of lung diseases. It is important for countries to implement tests based on the World Health Organization Essential Diagnostics List.
- Published
- 2023
- Full Text
- View/download PDF